Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne

Journal of Microencapsulation

Volumn 24, Issue 5, 2007, Pages 395-407

  Castro, Gisele A ^a   Oréfice, Rodrigo L ^a   Vilela, José M C ^b   Andrade, Margareth S ^b   Ferreira, Lucas A M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO CENTRO TECNOLÓGICO DE MINAS GERAIS   (Brazil)

Author keywords

Encapsulation efficiency; Retinoic acid; Solid lipid nanoparticles; Stearylamine

Indexed keywords

GLYCEROL BEHENATE; RETINOIC ACID; SOLID LIPID NANOPARTICLE;

ACNE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ENCAPSULATION; PARTICLE SIZE; TOPICAL TREATMENT; ZETA POTENTIAL;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; AMINES; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROSTATICS; EXCIPIENTS; FATTY ACIDS; HUMANS; KERATOLYTIC AGENTS; MICROSCOPY, POLARIZATION; NANOPARTICLES; OCTANOLS; PARTICLE SIZE; SOLUBILITY; TRETINOIN;

EID: 34347217899     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040701288519     Document Type: Article

References (40)

1. Alvarez-Román, R., Naik, A., Kalia, YN, Guy, RH and Fessi, H. (2004) Enhancement of topical delivery from biodegradable nanoparticles. Pharmaceutical Research, 21:10, pp. 1818-1825.
2. Alvarez-Román, R., Naik, A., Kalia, YN, Guy, RH and Fessi, H. (2004) Skin penetration and distribution of polymeric nanoparticles. Journal of Controlled Release, 99:1, pp. 53-62.
3. Bunjes, H., Koch, MH and Westesen, K. (2003) Influence of emulsifiers on the crystallization of solid lipid nanoparticles. Journal of Pharmaceutical Sciences, 92:7, pp. 1509-1520.
4. Cui, Z. and Mumper, RJ (2002) Topical immunization using nanoengineered genetic vaccines. Journal of Controlled Release, 81, pp. 173-184.
5. Dingler, A. and Gohla, S. (2002) Production of solid lipid nanoparticles (SLN): Scaling up feasibilities. Journal of Microencapsulation, 19:1, pp. 11-16.
6. Ellis, CN, Millikan, LE, Smith, EB, Chalker, DM, Swinyer, LJ, Katz, IH, Berger, RS, Mills Jr, OH, Baker, M. and Verschoore, M. (1998) Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in topical treatment of acne vulgaris. The British Journal of Dermatology, 139, pp. 41-47.
7. Freitas, C. and Muller, RH (1999) Correlation between long-term stability of solid lipid nanoparticles (SLN ™) and crystallinity of solid lipid phase. European Journal of Pharmaceutics and Biopharmaceutics, 47, pp. 125-132.
8. Gollnick, H. and Schramm, M. (1998) Topical drug treatment in acne. Dermatology, 196, pp. 119-125.
9. Gollnick, H., Cunliffe, W., Berson, D., Dreno, B., Finlay, A., Leyden, JJ, Shalita, AR and Thiboutot, D. (2003) Management of acne: A report from a global alliance to improve outcomes in acne. Journal of American Academy of Dermatology, 49, pp. S1-S38.
10. Tang, X. and Cui, F. (2004) Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Journal of Pharmacy and Pharmacology, 56, pp. 1527-1535.
11. Jenning, V. and Gohla, S. (2001) Encapsulation of retinoids in solid lipid nanoparticles (SLN®). Journal of Microencapsulation, 19:2, pp. 149-158.
12. Jenning, V., Lippacher, A. and Gohla, S. (2002) Medium scale production of solid lipid nanoparticles (SLN®) by high pressure homogenization. Journal of Microencapsulation, 19:1, pp. 1-10.
13. Jung, S., Otberg, N., Thiede, G., Richter, H., Sterry, W., Panzner, S. and Landemann, J. (2006) Innovative liposomes as a transfollicular drug delivery system: Penetration into porcine hair follicles. The Journal of Investigative Dermatology, 126:8, pp. 1728-1732.
14. Kayali, I., Ward, AJI, Suhery, T., Friberg, SE, Simion, A. and Rhein, LD (1991) Interactions of retinoic acid with a model of stratum corneum lipids. Journal of Dermal Clinical Evaluation Society, 2, pp. 7-17.
15. Lehmann, HP, Robison, KA, Andrews, JS, Holloway, V. and Goodman, SN (2002) Acne therapy: A methodologic review. Journal of American Academy of Dermatology, 47, pp. 231-240.
16. Leyden, J. (2003) A review of the use of combination therapies for the treatment of acne vulgaris. Journal of American Academy of Dermatology, 49, pp. S200-S210.
17. Lim, S. and Kim, C. (2002) Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. International Journal of Pharmaceutics, 243, pp. 135-146.
18. Lim, S., Lee, M. and Kim, C. (2004) Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticles powders. Journal of Controlled Release, 100, pp. 58-61.
19. Lucky, AW, Cullen, SI, Jarratt, MT and Quigley, JW (1998) Comparative efficacy and safety of two 0.025% tretinoin gels: Results from a multicenter, double-blind, parallel study. Journal of American Academy of Dermatology, 38, pp. S17-S23.
20. Lucky, AW, Cullen, SI, Funicella, T., Jarratt, MT, Quigley, JW, Jones, T. and Reddick, ME (1998) Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris. Journal of American Academy of Dermatology, 38, pp. S24-S30.
21. Megwa, SA, Cross, SE, Benson, HA and Roberts, MS (2000) Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. Journal of Pharmacy and Pharmacology, 52:8, pp. 919-928.
22. Megwa, SA, Cross, SE, Whitehouse, MW, Benson, HA and Roberts, MS (2000) Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates. Journal of Pharmacy and Pharmacology, 52:8, pp. 929-940.
23. Mehnert, W. and Mäder, K. (2001) Solid lipid nanoparticles production, characterization and applications. Advanced Drug Delivery Reviews, 47, pp. 165-196.
24. Mills Jr, OH and Berger, RS (1998) Irritation potential of new topical tretinoin formulation and a commercially-avaiable tretinoin formulation as measured by patch testing in human subjects. The Journal of American Academy of Dermatology, 33, pp. S11-S16.
25. Mordon, S., Sumian, C. and Devoisselle, JM (2003) Site-specific methylene blue delivery to pilosebaceous structures using highly porous nylon microspheres: An experimental evaluation. Lasers in Surgery and Medicine, 33, pp. 119-125.
26. Müllerer, RH, Radtke, M. and Wissing, SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews, 54, pp. S131-S155.
27. Munster, U., Nakamura, C., Haberland, A., Jores, K., Mehnert, W., Rummel, S., Schaller, M., Korting, HC, Zouboulis, CC and Blume-Pevtavi, U. (2005) RU58841- myristate-prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie, 60, pp. 8-12.
28. Quigley, JW and Bucks, AW (1998) Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: A summary of preclinical and clinical investigations. The Journal of American Academy of Dermatology, 38, pp. S5-S10.
29. Rolland, A., Wagner, N., Chatelus, A., Shroot, B. and Schaefer, H. (1993) Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharmaceutical Research, 10, pp. 1738-1744.
30. Rzany, B. and Kahl, C. (2006) Epidemiology of acne vulgaris. Journal of the German Society of Dermatology, 4, pp. 8-9.
31. Skov, MJ, Quigley, JW and Bucks, DAW (1997) Topical delivery system for tretinoin: Research and clinical implications. Journal of Pharmaceutical Sciences, 86, pp. 1138-1143.
32. Sumian, CC, Pitre, FB, Gauthier, BE, Bouclier, M. and Mordon, SR (1999) A new method to improve penetration depth of dyes into follicular duct: Potential application for laser hair removal. Journal of American Academy of Dermatology, 41, pp. 172-175.
33. The United States Pharmacopoeia (2003) The National Formulary-USP 26 NF 21, pp. 1861-1862. United States Pharmacopoeial Convention, Rockville MD, USA
34. Trotta, M., Ugazio, E., Peira, P. and Pulitano, C. (2003) Influence of ion pairing on topical delivery of retinoic acid from microemulsions. Journal of Controlled Release, 86, pp. 315-321.
35. Vogt, A., Mandt, N., Landemann, J., Schaefer, H. and Blume-Peytavi, U. (2005) Follicular targeting-A promising tool in selective dermatotherapy. The Journal of Investigative Dermatology, 10, pp. 252-255.
36. Vogt, A., Combadiere, B., Hadam, S., Stieler, KM, Landemann, J., Schaefer, H., Autran, B., Sterry, W. and Blume-Peytavi, U. (2006) 40 nm, but not 750 or 1.500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. The Journal of Investigative Dermatology, 126, pp. 1316-1322.
37. Westesen, K., Bunjes, H. and Koch, MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. Journal of Controlled Release, 48, pp. 223-236.
38. Webster, GF (1998) Topical tretinoin in acne therapy. The Journal of American Academy of Dermatology, 39, pp. S38-S44.
39. Wester, RC, Patel, R., Nacht, S., Leyden, J., Melendres, J. and Mailbach, H. (1991) Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. The Journal of American Academy of Dermatology, 24, pp. 720-726.
40. White, GM (1998) Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. The Journal of American Academy of Dermatology, 39, pp. S34-S37.